| Literature DB >> 31153610 |
Abstract
Lymphoma is a common disease in companion animals. Although conventional chemotherapy has the potential to induce remission and prolong life, relapse is common, and novel treatments are needed to improve outcome. This review discusses recent modifications/adjustments to conventional standard of care therapy for canine and feline lymphoma, as well as cutting-edge immunotherapy and small-molecule-based approaches that are in varying stages of regulatory approval.Entities:
Keywords: Cancer; Canine; Chemotherapy; Feline
Mesh：
Substances：
Year: 2019 PMID： 31153610 DOI： 10.1016/j.cvsm.2019.04.004
Source DB: PubMed Journal: Vet Clin North Am Small Anim Pract ISSN： 0195-5616 Impact factor: 2.093